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Inositol poly- and pyrophosphates (InsPs and PP-InsPs) are an important group of metabolites and mediate
a wide range of processes in eukaryotic cells. To elucidate the functions of these molecules, robust
techniques for the characterization of inositol phosphate metabolism are required, both at the
biochemical and the cellular level. Here, a new tool-set is reported, which employs uniformly
13C-labeled compounds ([13C6]myo-inositol, [
13C6]InsP5, [
13C6]InsP6, and [
13C6]5PP-InsP5), in combination
with commonly accessible NMR technology. This approach permitted the detection and quantiﬁcation of
InsPs and PP-InsPs within complex mixtures and at physiological concentrations. Speciﬁcally, the
enzymatic activity of IP6K1 could be monitored in vitro in real time. Metabolic labeling of mammalian
cells with [13C6]myo-inositol enabled the analysis of cellular pools of InsPs and PP-InsPs, and uncovered
high concentrations of 5PP-InsP5 in HCT116 cells, especially in response to genetic and pharmacological
perturbation. The reported method greatly facilitates the analysis of this otherwise spectroscopically
silent group of molecules, and holds great promise to comprehensively analyze inositol-based signaling
molecules under normal and pathological conditions.Introduction
Small molecule messengers are key components in cellular
decision-making processes.1 Among those, inositol-based
signaling molecules occupy a privileged node and include
both water-soluble, diﬀusible messengers (best characterized by
inositol 1,4,5-trisphosphate, InsP3, a calcium releasing factor),
as well as the lipid-anchored phosphatidylinositol phosphates
(PtdInsPs).2–4 Within the class of soluble inositol phosphates
(InsPs) much research has recently focused on a unique, highly
phosphorylated subgroup, termed the inositol pyrophosphates
(PP-InsPs).5–7 In these molecules high-energy diphosphate
groups are attached to the inositol scaﬀold by the action of two
classes of evolutionarily conserved small molecule kinases, the
inositol hexakisphosphate kinases (IP6Ks) and the diphos-
phoinositol pentakisphosphate kinases (PPIP5Ks).8–11 Altered
activity of these kinases has been linked to hearing loss,
decrease in tumor cell motility, life-span extension and insulin
hypersensitivity.12–16 Consequently, the enzymes involved inPharmakologie, Robert-Ro¨ssle-Straße 10,
p-berlin.de
t zu Berlin, Brook-Taylor-Straße 2, 12489
olecular Cell Biology, University College
tion (ESI) available. See DOI:
hemistry 2019InsP and PP-InsP synthesis and turnover are becoming sought-
aer targets for treating wide-spread diseases, such as diabetes
and cancer. While genetic studies have provided key insights
into InsP and PP-InsP function, many questions regarding the
dynamic interconversion and turnover of these messengers, as
well as the regulation of the enzymes involved in their biosyn-
thesis remain unanswered.
Tritiated [3H]myo-inositol has been used extensively to
incorporate radioactive labels into cellular InsP species, and to
facilitate their detection aer resolution by strong anion
exchange chromatography (SAX-HPLC) (Fig. 1a).17 Use of this
method has led to many seminal ndings, but the requirement
for radioactivity and the limited compatibility with certain cell
lines restricts its applicability. A parallel approach circum-
vented the use of radioactivity by analyzing HPLC fractions in
the presence of a metal-dependent dye, but has remained
sparsely used.17 More recently, a method based on gel electro-
phoresis was reported.18 Here, the extracted InsPs and PP-InsPs
have to be enriched over TiO2 beads, and are then resolved on
a high-percentage polyacrylamide gel (PAGE) (Fig. 1a).19
Although the independence from radioactive tracers has
allowed more laboratories to employ this approach, the lack of
an InsP-specic analytical handle requires a more elaborate
sample preparation and is limited to the detection of only the
most highly phosphorylated InsPs.
While all methods mentioned above have been instrumental
to date, they do not provide structural information about the
InsPs and PP-InsPs, such as the clear distinction of theChem. Sci., 2019, 10, 5267–5274 | 5267
Fig. 1 Methods for the analysis of inositol polyphosphates. (a)
Radioactively labeled InsPs can be resolved via SAX-HPLC and the
amount of radioactivity in each fraction is analyzed. Alternatively, InsPs
are enriched with TiO2-beads from complex mixtures, subsequently
resolved via PAGE, and detected by staining with toluidine blue. (b)
13C-labeled InsPs can be directly measured in complex samples using
NMR spectroscopy.
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View Article Onlinestructural isomers of PP-InsPs. Themethods also lack the ability
to monitor conversion of InsP species in real time in vitro,
thereby forfeiting informative kinetic insight contained within
biochemical experiments. Furthermore, because of the various
separation and resolution steps, direct measurements in
complex samples, such as cell extracts, have not been possible
so far.
NMR spectroscopy can provide detailed information about
the chemical and structural environment of a nucleus solely
based on the chemical shi. For example, two-dimensional
1H,31P-NMR has been used to elucidate the structure of PP-
InsPs.20,21 Since experiments utilizing the 3J(1H,31P) coupling are
of limited sensitivity due to the ineﬃcient magnetization
transfer via these couplings, high analyte concentrations were
necessary. In addition, the low chemical shi dispersion and
the broad lines of 31P nuclei can limit the information
content.20,21 By contrast, the chemical shi dispersion of the
NMR-active nucleus 13C is superior to 31P and the sensitivity of
two-dimensional experiments is much better, due to an eﬃcient
magnetization transfer via 1J(1H,13C) one-bond couplings. Since
13C has a natural abundance of only approx. 1%, isotopic
labeling of selected compounds should provide targeted5268 | Chem. Sci., 2019, 10, 5267–5274information on these molecules in complex environments.
Indeed, labeling of small molecules and metabolites with 13C
has been applied widely to elucidate various metabolic path-
ways and processes.22–24 Consequently, 13C-labeled myo-inositol
(1), and the corresponding labeled InsPs and PP-InsPs, should
also enable NMR measurements at low, biologically relevant
analyte concentrations and within intricate samples (Fig. 1b).
Here, we report high yielding syntheses of 13C-labeled myo-
inositol and 13C-labeled inositol polyphosphates and their
subsequent applications. We employ the 13C-labeled InsPs to
monitor in vitro activity of IP6Ks in real time using NMR spec-
troscopy and consequently characterize the kinetic parameters
of IP6Ks. Moreover, we demonstrate metabolic labeling of two
mammalian cell lines with [13C6]myo-inositol, and subsequent
detection of the in vivo generated [13C6]InsP species within
a complex cell extract. These ndings highlight the utility and
applicability of 13C-labeled InsPs/PP-InsPs to improve our
understanding of their biochemistry and metabolism, and to
interrogate and elucidate their cellular functions.
Results and discussion
Enzymatic synthesis of [13C6]myo-inositol on a gram scale
To analyze inositol-based signaling molecules by NMR we rst
sought to prepare pure [13C6]myo-inositol on a large scale. The
approaches to obtain 13C-labeled myo-inositol reported to date
have either relied on expensive [13C6]glucose-6-phosphate as
a starting material (7000V per g) or – when starting from [13C6]
glucose – were low yielding (9.9% and 6.7%, respectively).25–27 In
addition, all procedures lacked a scalable purication strategy
for the product, precluding the isolation of large and pure
amounts of product. Consequently, these methods have only
been applied on a small scale. To circumvent these limitations,
and to subsequently synthesize suﬃcient quantities of [13C6]
InsPs, we pursued a 3-step enzymatic synthesis that uses
aﬀordable [13C6]glucose (80V per g) as a starting material and
employed a chemical purication strategy at the end (Fig. 2).
As a rst step, [13C6]glucose (2) was phosphorylated at the 6-
position using commercially available hexokinase in a modied
literature procedure.28 Next, we optimized and scaled up the
isomerization reaction of [13C6]glucose-6-phosphate (3) to [
13C6]
myo-inositol-3-phosphate (4) published by Saiardi and
coworkers.25 Subsequently, 1 could be obtained by dephos-
phorylation using commercially available alkaline phosphatase.
While the desired product was clearly visible in the 13C-NMR
spectrum, the isolated yield exceeded 100%, indicative of
contamination with salts and buﬀer components. Because
purication of 1 by ion-exchange, normal-phase, and reverse-
phase chromatography proved diﬃcult, we applied a chemical
derivatization strategy in which the product mixture containing
1 was treated with an excess of acetic anhydride in pyridine. The
resulting [13C6]myo-inositol hexakisacetate (S1) could be puri-
ed by normal-phase chromatography, and subsequent sapon-
ication provided gram amounts of 1 in excellent purity with
a 50% overall yield (with respect to [13C6]glucose). In compar-
ison to previous syntheses, our approach provides a simpler and
shorter route with greatly improved yield.This journal is © The Royal Society of Chemistry 2019
Fig. 2 Enzymatic synthesis of [13C6]myo-inositol followed by derivatization and puriﬁcation. (i) MOPS pH 6.5, creatine phosphate, ATP, DTT,
MgCl2, hexokinase, creatine kinase in H2O at rt. (ii) Tris pH 8.0, NAD
+, NaCl, MgCl2, inositol phosphate synthase in H2O at 80 C. (iii) Glycine pH
9.8, ZnCl2, alkaline phosphatase in H2O at 35 C. (iv) Ac2O in pyridine at 120 C. (v) NaOMe in MeOH at rt.
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View Article OnlineChemical synthesis of [13C6]InsP5, [
13C6]InsP6 and enzymatic
synthesis of [13C6]5PP-InsP5
With large quantities of pure 1 at hand, we wanted to prepare
the 13C-labeled inositol polyphosphates [13C6]InsP5 (5), [
13C6]
InsP6 (6) and [
13C6]5PP-InsP5 (7), since InsP5 and InsP6 are the
most abundant soluble inositol phosphates in mammalian
cells, and 5PP-InsP5 is the best characterized inositol pyro-
phosphate messenger.6,29 The chemical syntheses of 5 and 6
were conducted according to published procedures for the
unlabeled compounds, and both 5 and 6 were isolated in good
yield (Fig. 3a). The HMQC spectra of 5 and 6 displayed four
resonances, due to the plane of symmetry in these molecules
(Fig. 3b and c). Importantly, the spectra depicted in Fig. 3 were
recorded at an InsP concentration of 5 mM, using only 32 scans,
and illustrate the high sensitivity provided by labeling with 13C.Fig. 3 Synthesis and characterization of [13C6]inositol polyphosphates.
DMSO at 80 C; 85% yield (ii) TFA in H2O at rt; quantitative yield (iii) 5-phe
Pd(OH)2/C in MeOH/H2O at rt; 88% yield (v) NH3 (aq.) at 60 C; 65% yield
(vii) Pd(OH)2/C in MeOH/H2O at rt; 83% yield (viii) MES pH 6.4, NaCl, ATP
yield (b) 1H,13C-HMQC spectrum of [13C6]InsP5 at 5 mM. (c)
1H,13C-HMQC
5PP-InsP5 at 5 mM. The positions of the carbon atoms and the solvent s
This journal is © The Royal Society of Chemistry 2019Compared to the syntheses of 5 and 6, obtaining [13C6]5PP-
InsP5 (7) by chemical means would be more challenging.
Although synthetic access to 5PP-InsP5 has been improved
signicantly in recent years, the syntheses still require several
synthetic steps, and provide an overall yield of 6–8% starting
from myo-inositol.30,31 Therefore, we focused our eﬀorts on an
enzymatic synthesis utilizing [13C6]InsP6 (6) as a substrate, to
conserve as much labeled material as possible. Specically, we
used ehIP6KA, an IP6K from Entamoeba histolytica, to produce 7
in one step from 6, as this enzyme has the highest reported
activity of all known IP6Ks.32 Within 45 minutes we observed
full conversion of 6 using an ATP regenerating system (Fig. 3a
and S1†).
The isolation of enzymatically generated PP-InsPs previously
relied on SAX-HPLC separation, or purication via PAGE.33,34(a) Reagents and conditions: (i) CSA, trimethyl orthobenzoate, TEA in
nyltetrazole, xylyl phosphoramidite,mCPBA in DCM at rt; 79% yield (iv)
(vi) xylyl phosphoramidite, 1H-tetrazole,mCPBA in DCM at rt; 38% yield
, creatine phosphate, MgCl2, DTT, IP6KA in H2O at 37 C; quantitative
spectrum of [13C6]InsP6 at 5 mM. (d)
1H,13C-HMQC spectrum of [13C6]
ignal are indicated.
Chem. Sci., 2019, 10, 5267–5274 | 5269
Fig. 4 Kinetic characterization and inhibition of IP6K1. (a) Michaelis–
Menten kinetics for IP6K1. The initial velocity wasmeasured in triplicate
at diﬀerent ATP concentrations and ﬁtted against a model for substrate
inhibition. (b) The inhibitory eﬀects of TNP (N2-(m-triﬂuorobenzyl)-
N6-(p-nitrobenzyl)purine), Myricetin, and Wortmannin were tested
and the IC50 values were determined. The ATP concentration was
2.5 mM for all inhibitor measurements (‡ enzyme activity at 0 mM
inhibitor).
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View Article OnlineWhile these methods indeed aﬀorded the desired materials, the
methods could only be conducted on a small scale, and typically
resulted in contamination of the product with large amounts of
salt. To overcome these limitations, a purication protocol was
developed in which the addition of magnesium ions caused
precipitation of the PP-InsP.35,36 Subsequent metal chelation
chromatography provided [13C6]5PP-InsP5 (7) as an ammonium
salt with excellent purity and quantitative isolated yield (Fig. 3a
and d).
Overall, the enzymatic synthesis, coupled to a new precipi-
tation protocol, can deliver large quantities of 5PP-InsP5 in
a short amount of time and constitutes a signicant improve-
ment in the accessibility of 5PP-InsP5 to researchers across
disciplines.
In situ measurement of IP6K activity
While optimizing the enzymatic synthesis of 7, we noted that
the progression of the reaction could be followed readily by
NMR, even in the presence of high concentrations of non-
deuterated buﬀer and ATP (Fig. S1†). Specically, the diag-
nostic signals for the protons at the 2-position of the inositol
ring of [13C6]InsP6 and [
13C6]5PP-InsP5 were baseline-separated
in the 1H-dimension (5.05 ppm for 6, 4.95 ppm for 7) and
showed no overlap with signals from other reaction compo-
nents within the mixture (Fig. S1†). The ability to resolve the 1H-
signals at the 2-position provided the opportunity to monitor
the enzymatic reaction in a time-resolved fashion, using
a pseudo-2D spin-echo diﬀerence experiment. This pulse
sequence is similar to the 1H,13C-HMQC experiments and
results in a series of one-dimensional spectra that only display
resonances for 1H-nuclei that are bound to 13C-nuclei. By plot-
ting the peak intensity of the 1H-nuclei at the 2-position against
time (each experiment required only 75 seconds at a substrate
concentration of 175 mM) the progress of the kinase reaction
could be observed (Fig. S2†). The non-invasive nature of the
NMR measurements allowed for continuous reaction moni-
toring, providing time-resolved data from one sample.
Determination of kinetic parameters for IP6K1 using NMR
Considering our ability to reliably measure kinase activity by
NMR, we next wanted to determine the kinetic parameters for
human IP6K1. Measurement of the initial rates at constant
InsP6 concentration (175 mM) and varying ATP concentrations
(62.5 mM to 8 mM) provided the Michalis–Menten constant (KM)
for ATP and the maximum velocity (Vmax) for IP6K1 (Fig. 4a).
The KM measured for ATP (353 167 mM) was comparable to
previous reports and is close to cellular ATP concentrations,
which supports the proposition that the IP6Ks are uniquely
sensitive to ATP availability.37,38 The Vmax value (192  41
nmol min1 mg1) for IP6K1 was also within the range of
published literature values, which varied greatly depending on
the protein-tag and purication strategy (37.3 nmol min1 mg1
to 1410 nmol min1 mg1).37,39 Interestingly, we found that ATP
concentrations above 2 mM led to substrate inhibition of IP6K1
(Ki 7.48 mM), which had not been quantied before (Fig. 4a).39
The robust measurements of InsP conversion by NMR5270 | Chem. Sci., 2019, 10, 5267–5274spectroscopy has provided kinetic data with low experimental
error, which, in turn, has allowed the observation of substrate
inhibition by ATP.
Measuring the potency of IP6K inhibitors
IP6Ks regulate important aspects of metabolism and signaling
in mammals and in pathogenic microorganisms like Trypano-
soma brucei and therefore increased eﬀorts to identify selective
inhibitors have been made.38,40,41 Thus far, two molecules, TNP
(N2-(m-triuorobenzyl)-N6-(p-nitrobenzyl)purine), and myricetin
have been shown to inhibit IP6K1 activity at low micromolar
concentrations. The potency of the inhibitors was characterized
using radiolabeled InsPs in the case of TNP, and an indirect
ATP-consumption assay for myricetin.38,40 Given that we could
directly measure product formation, we expanded the scope of
our NMR method towards the characterization of IP6K1 inhib-
itors. Indeed, we found that TNP and myricetin inhibited IP6K1
with IC50 values of 2.25 mM and 0.6 mM, respectively, while
wortmannin, a PI3K inhibitor, did not aﬀect enzyme activity,This journal is © The Royal Society of Chemistry 2019
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View Article Onlineeven at high concentrations (Fig. 4b). While the NMR based
method is not compatible with high-throughput screening to
identify new kinase inhibitors, it provides a direct read-out of
the substrate and the reaction product and is highly reliable.
This type of assay can thus serve as a platform to develop suit-
able high-throughput screening approaches for the kinases and
phosphatases involved in InsP metabolism and can ultimately
provide the necessary validation for the discovered inhibitors.Metabolic labeling of mammalian cells with [13C6]myo-
inositol
To date, the most widely used method to assay cellular InsP and
PP-InsP levels employs metabolic labeling of the cells with
tritiated, radioactive myo-inositol. Aer incorporation into the
cellular InsP and PP-InsP pools, the labeled compounds are
extracted, fractionated via SAX-HPLC chromatography, and
analyzed using scintillation counting (Fig. 1a). We envisioned to
replace [3H]myo-inositol with [13C6]myo-inositol and tested the
metabolic labeling of the human colon cancer cell line HCT116.
HCT116 cells were grown in the presence of 100 mM [13C6]myo-
inositol and subsequently lysed using 1 M HClO4. The extract
was neutralized, lyophilized, dissolved in D2O, and a
1H,13C-
HMQC spectrum was recorded (Fig. 5a). The spectrum dis-
played several strong peaks in the characteristic chemical shi
region for InsPs and PP-InsPs (1H: 5.0–3.6 ppm; 13C: 81–71 ppm,
Fig. 5b). At high spectral resolution a characteristic triplet
pattern emerged due to the coupling of neighboring 13C nuclei
in themyo-inositol ring. Comparison to an extract prepared with
[12C6]myo-inositol conrmed that these peaks were a result of
labeling with [13C6]myo-inositol (Fig. S3†). To verify that theFig. 5 Metabolic labeling of mammalian cell line HCT116, followed by
extracts for NMR spectroscopy. (b) Left: 1H,13C HMQC spectrum of an H
0 and 3 ppm are folded into an empty region of the spectrum. Right: the in
identiﬁed InsPs are annotated while peaks that exhibit the expected splitti
myo-inositol (Ins), InsP5, InsP6, nor 5PP-InsP5 are highlighted by red arro
This journal is © The Royal Society of Chemistry 2019labeling success was not limited to HCT116 cells, we next
treated human embryonic kidney cells (HEK293T) with [13C6]
myo-inositol and observed robust labeling again (Fig. S4†).
To annotate characteristic resonances for endogenous InsP5,
InsP6 and 5PP-InsP5, we performed spike-in experiments with
synthetic standards on the labeled extracts (Fig. S5†) and
conrmed the presence of the above mentioned InsPs (as
annotated in Fig. 5b). We further added a mixture containing
synthetic InsP5, InsP6 and 5PP-InsP5 to an unlabeled extract
from HCT116 and detected all signals at their expected chem-
ical shis (Fig. S6†).
For absolute quantication of InsP5, InsP6 and 5PP-InsP5, we
prepared [13C6]myo-inositol labeled HCT116 extracts containing
a known concentration of an internal standard (tetramethyl
phosphonium bromide, PMe4Br). Resonances corresponding to
the C2-position were integrated and referenced to a set of cali-
bration curves (Fig. S6†). Assuming full replacement of the
unlabeled InsP pools we calculated respective concentrations of
26.7  2.3 mM InsP5, 29.4  7.6 mM InsP6, and 1.9  0.5 mM PP-
InsP5, based on packed cell volume (Fig. 6a; Table S1†). The
measured concentrations are consistent with previous publi-
cations with respect to InsP5 and InsP6, however, the amount of
5PP-InsP5 determined by NMR is at least 2-fold higher.29,42
These results underline the mild sample preparation and the
quantitative nature of NMR spectroscopy and highlight its
potential for future measurements of labeled cells or tissues.Metabolic labeling of cells with perturbed PP-InsP levels
The ability to quantify mixtures of InsP messengers prompted
us to analyze the concentrations of InsP5, InsP6 and 5PP-InsP5NMR analysis. (a) General workﬂow for the preparation of whole cell
CT116 extract. The peaks from 80 to 100 ppm in the F1 and between
ositol phosphate region of the spectrum is depicted inmore detail. The
ng pattern in the carbon dimension but could not be attributed to either
ws.
Chem. Sci., 2019, 10, 5267–5274 | 5271
Fig. 6 Changes in 5PP-InsP5 levels can be observed by NMR spectroscopy. (a)
1H,13C HMQC spectrum of a HCT116 wt cell extract. (b) 1H,13C
HMQC spectrum of an extract of HCT116 wt cells treated with 10 mM NaF before extraction. (c) 1H,13C HMQC spectrum of HCT116 PPIP5K/
cell extract. The inserts display triplicates of absolute cellular concentration of InsP5, InsP6 and 5PP-InsP5 based on packed cell volume.
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
3 
A
pr
il 
20
19
. D
ow
nl
oa
de
d 
on
 6
/7
/2
01
9 
2:
28
:4
3 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinein HCT116 cells with perturbed PP-InsP metabolism. When
HCT116 cells were treated for one hour with 10 mM sodium
uoride (NaF), an agent previously shown to elevate 5PP-InsP5
levels,43 the content of 5PP-InsP5 increased dramatically to an
absolute concentration of 14.7  2.0 mM (Fig. 6b; Table S1†).
Elevated concentrations of 5PP-InsP5 were also reported in cells
lacking PPIP5K1 and PPIP5K2.44 We therefore grew PPIP5K/
cells and indeed, a general increase of 5PP-InsP5 was detected
compared to HCT116 wt cells (Fig. 6c, Table S1†). Addition of
NaF to this knock-out cell line resulted in extracts which con-
tained more 5PP-InsP5 than InsP6 or InsP5 (Fig. S7, Table S1†).
These trends of increasing 5PP-InsP5 concentrations had been
observed before and the ratio of 5PP-InsP5 to InsP6 in all our
samples was consistent with a previous report.44[13C6]myo-Inositol is further metabolized
To our surprise, the analysis of the mammalian extracts
uncovered additional NMR signals that displayed a triplet-
pattern in the carbon-dimension. These signals were absent
in the corresponding samples prepared with unlabeled myo-
inositol and must therefore stem from metabolic labeling with
[13C6]myo-inositol (Fig. 5b and S3†). Interestingly, several of
these signals increased upon NaF treatment (Fig. 6b). To
determine whether these signals correspond to other InsP or
PP-InsP species, the 13C-labeled, NaF treated HCT116 wt extract
was incubated with TiO2 beads, which enrich phosphate con-
taining molecules.19,45 In addition to retaining InsP5, InsP6 and
5PP-InsP5, a putative unsymmetrical InsP species (InsP1 or
InsP2) could be observed (Fig. S8†). Nevertheless, most unas-
signed labeled resonances were not bound by the TiO2 beads.
To test for conversion of myo-inositol to metabolically linked
molecules, spectra of D-chiro-inositol, scyllo-inositol and glu-
curonic acid were recorded (Fig. S9†), none of which were
superimposable with our unassigned labeled species.46,47 Lastly,
we considered that the additional peaks may be attributed to
PtdInsPs. However, aer a phospholipid extraction, the
aqueous layer still contained the unidentied resonances,5272 | Chem. Sci., 2019, 10, 5267–5274strongly implying a non-lipid, hydrophilic character of these
molecules (Fig. S9†). These observations suggest that the sup-
plemented [13C6]myo-inositol has been diverted into an
unknown metabolic pathway. Detection of these unanticipated
species was only possible because the NMR-analysis was con-
ducted on the crude extract and did not require a separation
step. Elucidating the structure and function of these molecules
connected to inositol metabolism will be of interest in the
future.Conclusion
Inositol-containing molecules are ubiquitous in nature. Yet,
their detection and quantication has proven to pose a formi-
dable challenge, as these molecules typically lack a handle that
would facilitate their analysis. Therefore, researchers in the
eld rely strongly on separation techniques and radioactive
tools to answer the biological questions surrounding these
metabolites.48 We now provide a new set of methods, which
emanate from access to benign 13C-labeled compounds, in
combination with commonly accessible NMR technology. This
approach has enabled the detection and quantication of InsPs
and PP-InsPs within complex mixtures. Specically, the 13C-
labeled compounds could be employed to biochemically char-
acterize the enzymatic activity of IP6K1 in real time. In addition,
the non-toxic nature of [13C6]myo-inositol allowed for metabolic
labeling of mammalian cells, followed by detection of the
generated InsP and PP-InsP species, without the need for
separation or enrichment. Furthermore, the structural infor-
mation gained by the NMR analysis ensured reliable assign-
ment of the identity of the detected InsP species.
In the future, the facile applicability of this method will allow
for the interrogation of new, or more complex, biological
questions. On the biochemical side, for example, characteriza-
tion of InsP- and PP-InsP phosphatases will benet greatly from
the structural information provided by the NMRmeasurements,
and the substrate specicity of these enzymes can beThis journal is © The Royal Society of Chemistry 2019
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View Article Onlineunequivocally determined. Additionally, new enzymes that have
been, or will be, found to metabolize InsPs can be characterized
more easily, and the reaction products can be assigned with
certainty.
We also envision an important application for the labeled
InsPs and PP-InsPs to gain better structural insights into their
interactions with proteins. To date, the only known canonical
binding domain for the highly phosphorylated inositols is the
SPX-domain, but many other proteins physically interact with
these metabolites.49 Instead of isotopically labeling these
proteins to investigate their ligand-binding via NMR, applying
a labeled ligand can have advantages. For example, using a 13C-
labeled mannose trisaccharide has recently informed the
binding mode between the sugar and its protein binding
domain.50 By analogy, the 13C-labeled compounds reported here
could help to obtain structural information on the conforma-
tion and the biochemical environment of the InsP ligands.
Closely related to InsP messengers are the lipid-anchored
phosphatidyl inositols (PtdInsPs), which are crucial in
signaling and occupy a pivotal role in health and disease.3
Following the procedure established here for metabolic
labeling, but isolating and analyzing the membrane fractions
instead, may provide important information on this group of
messengers. Considering that the PtdInsPs and InsPs are
metabolically linked, concomitant analysis of both groups of
molecules could uncover unprecedented information on the
coordination of these two messenger networks. While NMR
suﬀers from an innate low sensitivity, advances using hyper-
polarization methods in recent years have greatly enhanced the
signal of 13C nuclei and could help to increase the sensitivity of
our method in order to reliably detect inositol phosphates of
low abundance, such as 1PP-InsP5 and InsP8, or PtdInsPs via
NMR.51,52
Overall, [13C6]InsPs expand the analytical tool-box to inter-
rogate inositol based messengers and their role and regulation
at a biochemical and cellular level.
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